Kentucky 2026 Regular Session

Kentucky House Bill HB25

Introduced
1/6/26  
Refer
1/6/26  

Caption

AN ACT relating to coverage for scalp cooling systems used in connection with chemotherapy treatment for breast cancer.

Impact

If enacted, HB25 would amend existing health insurance statutes to include specific provisions ensuring that scalp cooling systems are covered under health insurance plans. This change is expected to impact many breast cancer patients, potentially enhancing their quality of life during a challenging treatment period. The implications for health insurance providers include adopting new protocols for reimbursement and ensuring that scalp cooling technologies are recognized as legitimate treatment adjuncts within the healthcare system.

Summary

House Bill 25 aims to mandate that health plans operating within the state provide coverage for scalp cooling systems used during chemotherapy treatments for breast cancer patients. The bill defines a 'health plan' broadly to include any health insurance policy that offers coverage for chemotherapy and specifies that scalp cooling systems are devices intended to mitigate hair loss associated with chemotherapy. The proposed legislation is a response to concerns expressed by patients about the emotional and psychological impact of hair loss during cancer treatment.

Sentiment

Overall, the sentiment surrounding HB25 appears to be supportive, particularly among patient advocacy groups and those affected by breast cancer treatments. Advocates argue that allowing access to scalp cooling systems is an important step toward making the chemotherapy process more humane. However, concerns have been raised by some stakeholders about the financial impact on insurance providers. The legislation has sparked discussions about the balance between emerging medical technologies and traditional health insurance paradigms.

Contention

Notable points of contention include the cost implications for health insurers and whether mandating coverage for scalp cooling systems could set a precedent for similar requests in the future regarding other cosmetic or supportive treatments. Additionally, discussions around how the bill would align with federal health regulations and standards of care may further complicate its passage.

Companion Bills

No companion bills found.

Previously Filed As

KY HB633

AN ACT relating to mental health coverage in connection with pregnancy.

KY HB683

AN ACT relating to coverage for the treatment of postpartum mood disorders.

KY HB506

AN ACT relating to chronic pain treatments.

KY HB691

AN ACT relating to coverage for the care of children.

KY HB236

AN ACT relating to coverage for epinephrine devices.

KY HB245

AN ACT relating to coverage for emergency ground ambulance services.

KY HB627

AN ACT relating to coverage for perinatal mood and anxiety disorders screenings.

KY SB93

AN ACT relating to coverage for hearing loss.

KY HB539

AN ACT relating to coverage for substance use disorder.

KY HB540

AN ACT relating to coverage for COVID-19 testing.

Similar Bills

No similar bills found.